Publications by authors named "WD Weaver"

Claim this Profile
I
Interleukin-18 in patients with acute coronary syndromes.
Axel Åkerblom, Stefan K James, Tatevik G Lakic, Richard C Becker, Christopher P Cannon, W Douglas Weaver

Clin Cardiol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy.
Amel Karaa, Richard Haas, Amy Goldstein, Jerry Vockley, W Douglas Weaver

Neurology· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
Claes Held, Harvey D White, Ralph A H Stewart, Andrzej Budaj, Christopher P Cannon, W Douglas Weaver

J Am Heart Assoc· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Daniel Lindholm, Stefan K James, Maria Bertilsson, Richard C Becker, Christopher P Cannon, W Douglas Weaver

Clin Chem· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial).
Yazan Daaboul, Serge Korjian, W Douglas Weaver, Robert A Kloner, Robert P Giugliano

Am J Cardiol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study.
Ian T Meredith, Jean-François Tanguay, Dean J Kereiakes, Donald E Cutlip, Robert W Yeh, W Douglas Weaver

Circulation· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention.
C Michael Gibson, Robert P Giugliano, Robert A Kloner, Christoph Bode, Michal Tendera, W Douglas Weaver

Eur Heart J· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes.
John P Vavalle, Sean van Diepen, Robert M Clare, Judith S Hochman, W Douglas Weaver

Am Heart J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letters regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement".
Kirk N Garratt, W Douglas Weaver, Ronald G Jenkins, Thomas K Pow, Laura Mauri

Circulation· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.
Robert W Yeh, Matthew J Czarny, Sharon-Lise T Normand, Dean J Kereiakes, David R Holmes, W Douglas Weaver

Circ Cardiovasc Qual Outcomes· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement.
Kirk N Garratt, W Douglas Weaver, Ronald G Jenkins, Thomas K Pow, Laura Mauri

Circulation· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of hospital outliers in bleeding complications after percutaneous coronary intervention.
Connie N Hess, Sunil V Rao, Lisa A McCoy, Megan L Neely, Mandeep Singh, W Douglas Weaver

Circ Cardiovasc Qual Outcomes· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of extreme-risk cases on hospitals' risk-adjusted percutaneous coronary intervention mortality ratings.
Matthew W Sherwood, J Matthew Brennan, Kalon K Ho, Frederick A Masoudi, John C Messenger, W Douglas Weaver

JACC Cardiovasc Interv· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
Michelle L O'Donoghue, Eugene Braunwald, Harvey D White, Mary Ann Lukas, Elizabeth Tarka, W Douglas Weaver

JAMA· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darapladib for preventing ischemic events in stable coronary heart disease.

N Engl J Med· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost analysis of endovenous catheter ablation versus surgical stripping for treatment of superficial venous insufficiency and varicose vein disease.
Judith C Lin, David R Nerenz, Pauline Migliore, Robert Young, Alexander D Shepard, W Douglas Weaver

J Vasc Surg Venous Lymphat Disord· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letters regarding article, "comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice: the assessing angiography (A2) project".
Brahmajee K Nallamothu, John A Spertus, Alexandra J Lansky, David J Cohen, Philip G Jones, W Douglas Weaver

Circulation· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.
Akshay Bagai, Paul W Armstrong, Amanda Stebbins, Kenneth W Mahaffey, Judith S Hochman, W Douglas Weaver

Am Heart J· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry).
J Matthew Brennan, Jeptha P Curtis, David Dai, Susan Fitzgerald, Akshay K Khandelwal, W Douglas Weaver

JACC Cardiovasc Interv· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice: the Assessing Angiography (A2) project.
Brahmajee K Nallamothu, John A Spertus, Alexandra J Lansky, David J Cohen, Philip G Jones, W Douglas Weaver

Circulation· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
Anjan K Chakrabarti, Kristin Feeney, Cassandra Abueg, David A Brown, Ewa Czyz, W Douglas Weaver

Am Heart J· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary intervention.
Issam Moussa, Anthony Hermann, John C Messenger, Gregory J Dehmer, W Douglas Weaver

Heart· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of preventive cardiology training among United States cardiology fellowships and comparison to training guidelines.
Quinn R Pack, Steven J Keteyian, Patrick E McBride, W Douglas Weaver, Henry E Kim

Am J Cardiol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights.
Sean van Diepen, Petr Widimsky, Renato D Lopes, Kyle R White, W Douglas Weaver

Circ Cardiovasc Qual Outcomes· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International variation in and factors associated with hospital readmission after myocardial infarction.
Robb D Kociol, Renato D Lopes, Robert Clare, Laine Thomas, Rajendra H Mehta, W Douglas Weaver

JAMA· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis